Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series

Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series

Among individuals receiving an adequate pharmacological treatment for Major Depressive Disorder (MDD), only 30% reach a full symptom recovery; the remaining 70% will experience either a pharmacological response without remission or no response at all thus configuring treatment resistant depression (...

Full description

Bibliographic Details
Main Authors: Enrico Pessina, Azzurra Martini, Fabiola Raffone, Vassilis Martiadis
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Psychiatry
Subjects:
major depression
treatment resistance
cariprazine
augmentation
atypical antipsychotic
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1299368/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1299368/full

Similar Items